Year
- All
- 2021
- 2020
- 2019
- 2018
February 25, 2021 01:05 PM
Codexis Reports Fourth Quarter and Fiscal Year 2020 Financial Results
February 9, 2021 01:05 PM
Codexis Announces Expansion to New Facility to Accommodate Next Stage of Growth
February 3, 2021 01:05 PM
Codexis Appoints Dr. Esther Martinborough to its Board of Directors
January 13, 2021 04:00 AM
Codexis Introduces Improved Enzymes to Further Enhance Tate & Lyle’s Stevia and Allulose Production
December 2, 2020 08:10 PM
Codexis Announces Pricing of Public Offering of Common Stock
November 24, 2020 02:01 PM
Codexis and Casdin Capital Launch SynBio Innovation Accelerator
November 5, 2020 01:05 PM
Codexis Reports Third Quarter 2020 Financial Results
August 6, 2020 04:00 AM
Codexis Adds Dr. Jennifer L. Aaker to its Board of Directors
August 1, 2020 01:05 PM
Codexis Reports Second Quarter 2020 Financial Results
June 23, 2020 04:00 AM
Codexis and Molecular Assemblies Partner to Transform the Field of DNA Synthesis
June 16, 2020 01:05 PM
Codexis Announces the Election of New Directors at its Annual Meeting of Stockholders
May 7, 2020 01:05 PM
Codexis Reports First Quarter 2020 Financial Results
May 6, 2020 01:05 PM
Codexis Achieves Technology Transfer Milestone with Global Pharmaceutical Leader
May 5, 2020 04:00 AM
Codexis Expands and Strengthens its Leadership Team with Two Executive Hires
February 27, 2020 01:05 PM
Codexis Reports 2019 Fourth Quarter and Full Year Financial Results
December 23, 2019 04:00 AM
Codexis Announces License Agreement with Roche for Enzyme Used in Next Generation Sequencing
October 15, 2019 01:05 PM
Codexis’ Protein Engineering Forum Highlights Progress and Future Direction of the Field
August 6, 2019 01:04 PM
Codexis Names Ross Taylor Senior Vice President and Chief Financial Officer
June 20, 2019 04:00 AM
Casdin Capital Invests $50 Million in Codexis to Accelerate Strategic Growth Initiatives
February 26, 2019 01:05 PM
Codexis Reports 2018 Fourth Quarter and Full Year Financial Results
November 8, 2018 04:00 AM
Codexis Announces Results of Phase 1a Clinical Trial with CDX-6114
April 23, 2018 03:00 AM